E. Noordijk

发表

Response shift in quality of life measurement in early-stage breast cancer patients undergoing radiotherapy

S. Jansen, A. Stiggelbout, M. Nooij, 2004, Quality of Life Research.

Mantle-cell lymphoma: a population-based clinical study.

E. Noordijk, E. Schuuring, J. Hermans, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term cosmetic changes after breast-conserving treatment of patients with stage I-II breast cancer and included in the EORTC 'boost versus no boost' trial.

H. Putter, H. Bartelink, E. Noordijk, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Developing a population-based registry for patients with paraproteinemias or multiple myeloma.

E. Noordijk, J. Hermans, S. Snijder, 1997, Journal of clinical epidemiology.

Reply to editorial by Drs. Loeffler and Shrieve

E. Noordijk, J. Hermans, C. Vecht, 1994 .

The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age.

E. Noordijk, J. Tans, J. Hermans, 1994, International journal of radiation oncology, biology, physics.

Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987.

E. Noordijk, M. Tubiana, M. Henry-Amar, 1989 .

Circulating atrial natriuretic peptide plasma levels as a marker for cardiac damage after radiotherapy.

J. Wondergem, E. Noordijk, J. Leer, 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Sperm quality before treatment in patients with early stage Hodgkin’s lymphoma enrolled in EORTC-GELA Lymphoma Group trials

J. Raemaekers, E. Noordijk, H. Kluin-Nelemans, 2009, Haematologica.

Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer.

E. Noordijk, J. Hermans, J. Leer, 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized Trial.

D. de Jong, E. Noordijk, A. Stamatoullas, 2017, International journal of radiation oncology, biology, physics.

Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.

J. Raemaekers, A. Hagenbeek, G. Salles, 2007, The New England journal of medicine.

Clinical stages I and II Hodgkin's disease: a specifically tailored therapy according to prognostic factors.

E. Noordijk, E. Van Der Schueren, M. Henry-Amar, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Etude des Lymphomes de l'Adulte.

N. Le Stang, J. Raemaekers, E. Noordijk, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines.

E. Noordijk, L. Specht, Y. Lievens, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Premature ovarian failure and fertility in long-term survivors of Hodgkin's lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Etude des Lymphomes de l'Adulte Cohort Study.

J. Raemaekers, A. Allgeier, E. Noordijk, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Non-Hodgkin's Lymphoma in The Netherlands: Results from a Population Based Registry

S. le Cessie, E. Noordijk, P. Kluin, 2003, Leukemia & lymphoma.

Persistent improved results after adding vincristine and bleomycin to a cyclophosphamide/hydroxorubicin/Vm-26/prednisone combination (CHVmP) in stage III-IV intermediate- and high-grade non-Hodgkin's lymphoma. The EORTC Lymphoma Cooperative Group.

A. Hagenbeek, E. Noordijk, L. Bijnens, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment, patterns of failure, and survival of patients with Stage I nodal and extranodal non‐Hodgkin's lymphomas, according to data in the population‐based registry of the comprehensive cancer centre west

E. Noordijk, H. Kluin-Nelemans, J. Hermans, 1998, Cancer.

Cutaneous T‐cell lymphoma: clinicopathological relationships, therapy and survival in ninety‐two patients

E. Noordijk, C. Meijer, J. Hermans, 1982, The British journal of dermatology.

Chapter 5 CD 44 expression predicts disease outcome in localized large B-cell lymphomas

E. Noordijk, S. Heisterkamp, H. Kluin-Nelemans, 2017 .

Development of a "Myeloma Risk Score" using a population-based registry on paraproteinemia and myeloma.

E. Noordijk, J. Hermans, J. Kluin-Nelemans, 1997, Leukemia & lymphoma.

Treatment and survival of 38 female breast lymphomas: a population-based study with clinical and pathological reviews

J. Coebergh, E. Noordijk, M. Janssen-Heijnen, 2003, Annals of Hematology.

Radiotherapy is effective in patients with glioblastoma multiforme with a very limited prognosis and in patients above 70 years of age

E. Noordijk, C. Marijnen, R. Thomeer, 2003 .

Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.

E. Noordijk, R. Willemze, E. Schimmel, 2009, International journal of radiation oncology, biology, physics.

Erythrocyte Sedimentation Rate Predicts Early Relapse and Survival in Early-Stage Hodgkin Disease

E. Noordijk, M. Tubiana, J. Cosset, 1991 .

77 Combination of radiotherapy and chemotherapy is advisable in all patients with clinical stage I–II Hodgkin's disease six-year results of the EORTC-GPMC controlled clinical trials ‘H7-VF’, ‘H7-F’ and ‘H7-U’

A. Hagenbeek, E. Noordijk, U. Tirelli, 1997 .

Waldeyer's Ring Lymphomas: A Clinical Study from the Comprehensive Cancer Center West Population Based NHL Registry

S. Cessie, E. Noordijk, P. Kluin, 2001, Leukemia & lymphoma.

Gastric lymphomas compared with lymph node lymphomas in a population‐based registry differ in stage distribution and dissemination patterns but not in patient survival

E. Noordijk, H. Kluin-Nelemans, P. Blok, 1997, Cancer.

Staging and treatment of non‐Hodgkin's lymphoma of intermediate‐grade malignancy: A retrospectective study of 102 cases

E. Noordijk, J. Hermans, P. Kluin, 1987, European journal of haematology.

Is the Durie and Salmon diagnostic classification system for plasma cell dyscrasias still the best choice?

E. Noordijk, J. Hermans, J. Kluin-Nelemans, 2005, Annals of Hematology.

Parenthood in survivors of Hodgkin lymphoma: an EORTC-GELA general population case-control study.

J. Raemaekers, A. Allgeier, E. Noordijk, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breast Cancer Risk in Female Survivors of Hodgkin’s Lymphoma: Lower Risk After Smaller Radiation Volumes OF LINICAL NCOLOGY

A. Broeks, E. Noordijk, M. Louwman, 2009 .

Long-term outcome in endometrial carcinoma favors a two- instead of a three-tiered grading system.

E. Noordijk, V. Smit, C. Creutzberg, 2002, International journal of radiation oncology, biology, physics.

Radiotherapy in early stage Hodgkin's disease: principles and results of recent clinical trials.

E. Noordijk, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.

A. Broeks, E. Noordijk, M. Stovall, 2003, Journal of the National Cancer Institute.

The classification of plasma cell dyscrasias: alternatives to the Durie & Salmon diagnostic system.

E. Noordijk, J. Hermans, J. Kluin-Nelemans, 1999, Leukemia & lymphoma.

Late radiation injuries of the gastrointestinal tract in the H2 and H5 EORTC Hodgkin's disease trials: emphasis on the role of exploratory laparotomy and fractionation.

E. Noordijk, J. Cosset, E. Van Der Schueren, 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The achievements of the EORTC Lymphoma Group

J. Raemaekers, E. Noordijk, M. Glabbeke, 2002 .

Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma.

J. Baars, M. van Glabbeke, S. le Cessie, 2006, Blood.

Relative risk of cardiovascular disease after treatment for aggressive non-Hodgkin's lymphoma

J. Baars, S. Cessie, E. Noordijk, 2005 .

Primary extranodal non-Hodgkin's lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry.

S. Cessie, S. le Cessie, E. Noordijk, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Population-based registration of non-Hodgkin lymphoma in the region covered by the Comprehensive Cancer Centre West. The registry of diagnosis and therapy.

T. Stijnen, E. Noordijk, P. Kluin, 1986, The Netherlands journal of medicine.

Eye shielding during total body irradiation for bone marrow transplantation in children transplanted for a hematological disorder: risks and benefits

E. Noordijk, H. Kal, H. Struikmans, 2003, Bone Marrow Transplantation.

HLA-identical haematopoietic stem cell transplantation for acute leukaemia in children: less relapse with higher biologically effective dose of TBI

E. Noordijk, R. Geskus, H. Kal, 2007, Bone Marrow Transplantation.

Non-Hodgkin's lymphoma in the elderly

E. Noordijk, H. Kluin-Nelemans, E. Maartense, 2003, Annals of Hematology.

Elderly patients with non-Hodgkin's lymphoma: population-based results in The Netherlands.

E. Noordijk, J. Hermans, P. Kluin, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Total skin electron beam irradiation for cutaneous T‐cell lymphoma (mycosis fungoides)

E. Noordijk, W. Vloten, H. Vroome, 1985, The British journal of dermatology.

Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy.

E. Noordijk, R. Willemze, J. Rijlaarsdam, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutations.

A. Hagenbeek, A. Broeks, E. Noordijk, 2000, International journal of radiation biology.

Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.

J. Raemaekers, A. Hagenbeek, E. Noordijk, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hodgkin's lymphoma: basing the treatment on the evidence.

J. Connors, E. Noordijk, S. Horning, 2001, Hematology. American Society of Hematology. Education Program.

Radiation-induced lung damage after thoracic irradiation for Hodgkin's disease: the role of fractionation.

E. Noordijk, B. Dubray, H. Thames, 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.

A. Hagenbeek, E. Noordijk, J. H. Meerwaldt, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The EORTC trials for limited stage Hodgkin's disease. The EORTC Lymphoma Cooperative Group.

M Tubiana, E. Noordijk, M. Tubiana, 1992, European journal of cancer.

Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. EORTC Lymphoma Cooperative Group.

E. Noordijk, J. Cosset, M. Henry-Amar, 1990, International journal of radiation oncology, biology, physics.

Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987.

M Tubiana, A Tanguy, E. Noordijk, 1989, Blood.

International Prognostic Index for aggressive non-Hodgkin's lymphoma is valid for all malignancy grades.

J Hermans, E. Noordijk, J. Hermans, 1995, Blood.

Increased risk of second cancers in managing Hodgkin's disease: the 20-year Leiden experience

J. Vandenbroucke, E. Noordijk, J. Zwetsloot-Schonk, 1992, Annals of Hematology.

Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines.

E. Noordijk, L. Specht, Y. Lievens, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Techniques applied for total body irradiation.

J. J. Broerse, E. Noordijk, H. de Vroome, 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery

Ronald Brand, E. Noordijk, J. Tans, 1993, Annals of neurology.

Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation?

E. Noordijk, J. Hermans, J. Leer, 1996, International journal of radiation oncology, biology, physics.

Malignant mesothelioma after radiation treatment for Hodgkin lymphoma.

E. Noordijk, M. Louwman, M. D. De Bruin, 2009, Blood.

Long-term efficacy of the CHVmP/BV regimen used for aggressive non-Hodgkin's lymphoma in three randomised EORTC trials.

J. Baars, M. van Glabbeke, E. Noordijk, 2004, European journal of cancer.

Combined modality treatment of short duration in small cell lung cancer.

E. Noordijk, A. V. van Oosterom, J. Dijkman, 1984, European journal of cancer & clinical oncology.

CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group.

M Van Glabbeke, M. van Glabbeke, E. Noordijk, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of involved field radiotherapy in partial response after doxorubicin-based chemotherapy for advanced aggressive non-Hodgkin's lymphoma.

J. Baars, M. van Glabbeke, E. Noordijk, 2006, International journal of radiation oncology, biology, physics.

Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study.

J. Baars, M. van Glabbeke, E. Noordijk, 2006, Haematologica.

S. Cessie, S. le Cessie, E. Noordijk, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas.

R. Dummer, E. Noordijk, L. Cerroni, 2008, Blood.

Comparative analysis of risk factors for pathological fracture with femoral metastases.

E. Noordijk, C. Marijnen, J. Lok, 2004, The Journal of bone and joint surgery. British volume.

Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.

A. Broeks, E. Noordijk, M. Louwman, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.

M. Kersten, A. Hagenbeek, G. Salles, 2009, The Lancet. Oncology.

Results of hematopoietic stem cell transplantation after treatment with different high-dose total-body irradiation regimens in five Dutch centers.

E. Noordijk, R. Brand, H. Kal, 2008, International journal of radiation oncology, biology, physics.

recommendations for the management of cutaneous B-cell lymphomas International Society for Cutaneous Lymphoma consensus European Organization for Research and Treatment of Cancer and

R. Dummer, E. Noordijk, L. Cerroni, 2008 .

Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.

M. Hauptmann, E. Noordijk, M. D. De Bruin, 2009, International journal of radiation oncology, biology, physics.

Late effects of total body irradiation and cytostatic preparative regimen for bone marrow transplantation in children with hematological malignancies.

E. Noordijk, H. van den Berg, J. Vossen, 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials.

J. Raemaekers, J. Baars, M. van Glabbeke, 2005, Clinical lymphoma & myeloma.

Late relapse in early-stage Hodgkin's disease patients enrolled on European Organization for Research and Treatment of Cancer protocols.

E. Noordijk, J. Bosq, M. Henry-Amar, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Unstable Preferences:

S. Jansen, A. Stiggelbout, M. Nooij, 2000, Medical decision making : an international journal of the Society for Medical Decision Making.

Survival after Hodgkin lymphoma

E. Noordijk, N. Heutte, M. Henry-Amar, 2009, Cancer.

Nuclear beta-catenin is a molecular feature of type I endometrial carcinoma.

E. Noordijk, A. Scholten, C. Creutzberg, 2003, The Journal of pathology.

Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial.

I. Nagtegaal, E. Noordijk, C. Marijnen, 2003, International journal of radiation oncology, biology, physics.

ABVD or BEACOPPbaseline along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Étude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial.

J. Raemaekers, G. Salles, D. de Jong, 2017, European journal of cancer.

Impact of the boost dose on local control and survival in patients with early stage breast cancer after a microscopically incomplete lumpectomy : 10 years results of the randomised EORTC boost trial 22881/10882.

H. Bartelink, J. Horiot, M. Piérart, 2006 .

Spontaneous growth arrest of lung metastases of osteosarcoma with a 28-year follow-up. Netherlands Committee on Bone Tumours.

E. Noordijk, H. Kroon, R. O. van der Heul, 1994, European journal of cancer.

Individual quality of life: adaptive conjoint analysis as an alternative for direct weighting?

A. Stiggelbout, E. Noordijk, T. V. Vliet Vlieland, 2008, Quality of Life Research.

Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial.

E. van Limbergen, H. Bartelink, J. Horiot, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

1202 High-dose chemotherapy (HDC) with stemcell rescue for patients with metastatic Ewing's sarcoma

E. Noordijk, W. Fibbe, M. Nooy, 1995 .

Cryopreservation, semen use and the likelihood of fatherhood in male Hodgkin lymphoma survivors: an EORTC-GELA Lymphoma Group cohort study.

J. Raemaekers, B. Coiffier, A. Allgeier, 2014, Human reproduction.

First results of the EORTC-GELA H9 randomized trials: the H9-F trial (comparing 3 radiation dose levels) and H9-U trial (comparing 3 chemotherapy schemes) in patients with favorable or unfavorable early stage Hodgkin’s lymphoma (HL)

E. Noordijk, M. Henry-Amar, F. Morschhauser, 2005 .

Major complications of the central nervous system after bone marrow transplantation in children with acute lymphoblastic leukemia.

E. Noordijk, H. van den Berg, J. Vossen, 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Non-Hodgkin's lymphoma in the elderly. A review with emphasis on elderly patients, geriatric assessment, and future perspectives.

E. Noordijk, H. Kluin-Nelemans, E. Maartense, 2003, Annals of Hematology.

Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884).

J. Raemaekers, E. Noordijk, Y. Lievens, 2005, International journal of radiation oncology, biology, physics.

Combined Modality Treatment for Poor Prognosis Stages I and II Hodgkin's Disease.

E. Noordijk, B. Dubray, J. Cosset, 1996, Seminars in radiation oncology.

Answer to Dr. Suresh Senan

E. Noordijk, B. Aleman, P. Meijnders, 2007 .

Erythrocyte sedimentation rate predicts early relapse and survival in early-stage Hodgkin disease. The EORTC Lymphoma Cooperative Group.

E. Noordijk, M. Henry-Amar, P. Carde, 1991, Annals of internal medicine.

Training in radiotherapy in The Netherlands.

E. Noordijk, J. Leer, 1992, International Journal of Radiation Oncology, Biology, Physics.

Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Cu

J. Raemaekers, A. Hagenbeek, E. Noordijk, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group.

A. Hagenbeek, M. van Glabbeke, S. Pittaluga, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features in 50 cases.

E. Noordijk, C. Meijer, R. Willemze, 2005, Archives of dermatology.

Presenting signs and symptoms in multiple myeloma: High percentages of stage III among patients without apparent myeloma-associated symptoms

E. Noordijk, J. Hermans, J. Kluin-Nelemans, 1995, Annals of Hematology.

Different age limits for elderly patients with indolent and aggressive non‐Hodgkin lymphoma and the role of relative survival with increasing age

E. Noordijk, S. le Cessie, H. Kluin-Nelemans, 2000, Cancer.

Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study.

J. Baars, E. Noordijk, H. Kluin-Nelemans, 2006, Haematologica.

Apparent heart damage after mantle irradiation, caused by subclinical hypothyroidism.

E. Noordijk, J. Kluin-Nelemans, H. V. van Slooten, 1993, International Journal of Radiation Oncology, Biology, Physics.

European Organization for Research and Treatment of Cancer (EORTC) and International Society for Cutaneous Lymphoma (ISCL) consensus recommendations for the management of cutaneous B-cell lymphomas Short title for running head: management of cutaneous B-cell lymphoma

E. Noordijk, L. Cerroni, P. Bruzzi, 2008 .

Parenthood in survivors of Hodgkin lymphoma: An EORTC-GELA general population case-control study.

J. Raemaekers, A. Allgeier, E. Noordijk, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survival after Hodgkin lymphoma

E. Noordijk, N. Heutte, M. Henry-Amar, 2009, Cancer.